Wilson's disease treatment and diagnostics abroad

Wilson's disease (hepatolenticular degeneration) is a rare inherited disorder in which copper builds up in the body. It mainly affects the liver, the brain and the cornea of the eye. Untreated, it can lead to severe liver failure and neurological problems. Timely treatment can improve or prevent damage, but outcomes vary.

Below are clinics abroad that diagnose and treat Wilson's disease: compare their capabilities, doctors and individual estimates. Assessment often combines liver expertise with neurological care, depending on the findings. Diagnosis usually rests on several pieces of evidence rather than one copper or ceruloplasmin result. Treatment aims to control copper accumulation and prevent further damage, with continuing review even when the person feels well. For a second opinion, provide laboratory trends, urine collection results, genetic reports, eye findings and a dated treatment history. Ask how diagnosis, prescriptions, monitoring and family assessment will be coordinated before arranging care abroad.

Causes of Wilson's disease

The body needs copper in small amounts; normally the liver removes the excess into bile. In Wilson's disease a mutation in the ATP7B gene disrupts this process, so copper gradually builds up in the liver and may also accumulate in the brain, eyes, kidneys and other organs.

The disease is inherited in an autosomal recessive pattern: a child is affected only if they inherit the altered gene from both parents. Carriers of one disease-causing variant do not usually develop Wilson’s disease. It affects about one person in 30,000 and often appears in younger people, but can present outside the commonly cited 5–35-year range.

Symptoms

Liver involvement

• weakness, fatigue, loss of appetite;
• jaundice, abdominal pain;
• swelling and fluid in the abdomen (ascites);
• easy bruising and bleeding;
• acute hepatitis or acute liver failure — sometimes the first sign of the disease.

Wilson's disease should be considered in any unexplained liver disease, especially in young people.

Neurological and psychiatric signs

• tremor, stiffness, slow movements;
• problems with speech and swallowing, drooling;
• poor coordination and handwriting;
• mood and behaviour changes, depression, falling school performance.

Eye signs

A typical sign is Kayser–Fleischer rings: a golden-brown ring at the edge of the cornea. They are found in almost all patients with neurological symptoms and in about half of those with liver disease only. Their absence does not exclude the disease.

Diagnosis

Findings must be interpreted together: neither a single copper or ceruloplasmin result nor one eye finding settles the diagnosis. The team should explain whether further testing would resolve uncertainty.

• blood tests: liver function, ceruloplasmin and copper levels;
• 24-hour urinary copper;
• slit-lamp eye examination;
• brain MRI when there are neurological symptoms;
• liver biopsy with copper measurement — in unclear cases;
• ATP7B genetic testing — to support diagnosis and guide assessment of siblings and other first-degree relatives.

Treatment of Wilson's disease

Treatment is lifelong and has two goals: to remove excess copper and to prevent it from building up again.

• Copper chelators — penicillamine or trientine — bind copper and remove it in the urine. Regular blood and urine tests are needed because of possible side effects.
• Zinc reduces copper absorption from food; it may be used for selected maintenance or presymptomatic cases. It is not interchangeable with chelators; significant liver disease generally requires chelation.
• Diet — individual advice may limit copper-rich foods such as liver, shellfish, nuts and chocolate, especially initially. Diet does not replace medicines.
• Liver transplantation — transplant-team assessment for acute liver failure or selected advanced liver disease. Referral does not guarantee eligibility or an organ.

Neurological symptoms often improve with proper treatment but persist in some patients, so it is important to start treatment as early as possible.

Planning specialist care abroad

Ask about the following capabilities rather than assuming that care abroad is automatically better:

• experience in diagnosing rare diseases and genetic confirmation of the diagnosis;
• a multidisciplinary team: hepatologist, neurologist, ophthalmologist and geneticist;
• liver transplant programmes for severe cases.

See clinics in the gastroenterology, neurology and transplantology sections.

Send a request with your test results — Clinics Direct coordinators can help you request a specialist opinion and an individual treatment plan abroad.

Continuing monitoring

Review clinical progress, liver function, copper control and medicine safety. Do not stop or change treatment independently; discuss new neurological symptoms or pregnancy plans with the specialist. Rapid deterioration with jaundice, confusion or significant bleeding needs urgent local care, not a delayed overseas appointment. Agree who will monitor results at home.

Frequently asked questions

Can one blood result confirm the diagnosis?

Usually several clinical, biochemical and sometimes genetic findings are combined.

Can diet replace medicines?

No. Dietary advice supports treatment.

Do relatives without symptoms need assessment?

They may; family testing can identify disease before symptoms.

Can treatment stop after improvement?

Do not stop independently. Continuing therapy and monitoring are important.